medRxiv PreprintsInternational19 November 2026
Integrative Multi-Ancestry and Multi-Tissue Fine-Mapping Prioritizes Candidate Causal Genes for Risk of Breast Cancer and Its Subtypes
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Most breast cancer (BC) risk loci identified by genome wide association studies lie in noncoding regions, and traditional transcriptome-wide association studies (TWAS) often prioritize multiple correlated genes per locus. We applied two gene fine-mapping methods, TGVIS and M cTWAS, which jointly model gene expression, splicing and alternative polyadenylation (APA) with direct variant effects, to overall BC, estrogen receptor-negative (ER negative) BC and triple-negative BC (TNBC) in women of European and African ancestry. Using 11 BC-relevant GTEx v10 tissues, we prioritized 31, 13 and 5 candi
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.